Mereo Biopharma Group Plc Financial Overview
Mereo Biopharma Group Plc's market cap is currently $367.51M. The company's EPS TTM is $-0.01; its P/E ratio is -8.76; Mereo Biopharma Group Plc is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $0.00. See an overview of income statement, balance sheet, and cash flow financials.
